Term ends Jan 15, 2031 · High confidence
20-year base term ends Jun 9, 2029
Held by AbbVie Inc.
Filed Jun 9, 2009 as application 12/481,028 · Granted Feb 24, 2015
Base term plus 585 days of patent term adjustment (USPTO delay)
Today
2009
2031
Clock starts
Jun 9, 2009
Jun 9, 2009
Term ends
Jan 15, 2031
Jan 15, 2031
Granted
Feb 24, 2015
Feb 24, 2015
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
585
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 585 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 9, 2009, when this application, 12/481,028, was filed | Jun 9, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +585 days, USPTO patent term adjustment record | Jan 15, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 15, 2031 | High confidence |
This family
| US 8,962,629 | this patent Jan 2031 | Jan 2031 |
| US 8,426,411 | Surrendered on reissue Feb 2019 | Feb 2019 |
| Application 13/761,501 | Abandoned not computed | not computed |
| US 9,365,579 | In force Jun 2029 | Jun 2029 |
| Application 15/017,802 | Abandoned not computed | not computed |
| Application 15/152,823 | Abandoned not computed | not computed |
| US RE47,221 | In force Aug 2033 | Aug 2033 |
| Application 15/806,104 | Abandoned not computed | not computed |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 28, 2009 Reel 23014, frame 643 | Wishart, Neil; Argiriadi, Maria A.; Calderwood, David J.; Ericsson, Anna M.; Fiamengo, Bryan A.; Frank, Kristine E.; Friedman, Michael; George, Dawn M.; Goedken, Eric R.; Josephsohn, Nathan S.; Li, Biqin C.; Morytko, Michael J.; Stewart, Kent D.; Voss, Jeffrey W.; Wallace, Grier A.; Wang, Lu; Woller, Kevin R. | Abbott Laboratories | Assignment of Assignor's Interest |
| Apr 17, 2013 Reel 30237, frame 597 | Abbott Laboratories | AbbVie Inc. | Assignment of Assignor's Interest |
| Apr 30, 2019 Reel 49043, frame 808 | Abbott Laboratories | AbbVie Inc. | Corrective Assignment to Correct the Schedule a Previously Recorded on Reel 030237 Frame 0597. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2031
Term ends Jan 15, 2031. No further fees fall due before then
Note
The 585 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
124
later US patents cite this one
That is top 5% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.